Lunit partners with Radiobotics to enhance AI-assisted X-ray screening

Korean healthcare AI company Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, is to distribute its CE MDR Class IIa-certified AI tool RBfracture, designed for rapid and precise detection of bone fractures on X-ray images, under a strategic partnership agreed with Denmark-based Radiobotics, a musculoskeletal AI diagnostics provider.

When used alongside RBfracture, Lunit’s AI-powered chest X-ray screening solution Lunit INSIGHT CXR enhances the comprehensive diagnostic capabilities available to healthcare providers, offering a full spectrum of AI-assisted screening that spans lung abnormalities to bone fractures with a single X-ray.

The agreement furthermore allows Lunit to expand its diagnostic portfolio to include other X-ray diagnostic tools from Radiobotics, such as those for detecting knee osteoarthritis and hip dysplasia.

The partnership aims to strengthen both companies’ presence in the AI medical imaging market starting from EMEA.

Author

  • Matthew Brady

    Matt Brady is an award-winning storyteller and strategic communications advisor.

    A native Englishman with global experience spanning China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE, he founded HealthTechAsia and co-founded the non-profit Pul Alliance for Digital Health and Equity.

    He has led social media and communications initiatives for world leaders, corporations, and NGOs, and spearheaded editorial strategy for a portfolio of leading healthcare events and year-round publications — transforming coverage from print to digital — including Arab Health, Asia Health, Africa Health, FIME, and others. Earlier in his career, he held editorial roles at Microsoft and Johnson & Johnson.

    He received the 2021 Medical Travel Media Award from the Malaysia Healthcare Travel Council and a Guardian Student Media Award in 2000.

    View all posts

Discover more from HealthTechAsia

Subscribe to get the latest posts sent to your email.

Leave a Reply

Your email address will not be published. Required fields are marked *